|
Survival of clinical stage III NSCLC according to therapeutic strategy: Relevance of the tumor board decision in the era of immunotherapy |
|
|
|
Titel: |
Survival of clinical stage III NSCLC according to therapeutic strategy: Relevance of the tumor board decision in the era of immunotherapy |
Auteur: |
Benet, Justin Toffart, Anne-Claire Brichon, Pierre-Yves Chollier, Thibaut Ruckly, Stéphane Villa, Julie Emprou, Camille Pierret, Thomas Dumas, Isabelle Ferretti, Gilbert Moro-Sibilot, Denis Levra, Matteo Giaj |
Verschenen in: |
Cancer treatment and research communications |
Paginering: |
Jaargang 30 () nr. C pagina's p. |
Jaar: |
2022 |
Inhoud: |
|
Uitgever: |
The Author(s) |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|